Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling
AUTOR(ES)
Sanchez, Pilar
FONTE
National Academy of Sciences
RESUMO
Prostate cancer is the most common solid tumor in men, and it shares with all cancers the hallmark of elevated, nonhomeostatic cell proliferation. Here we have tested the hypothesis that the SONIC HEDGEHOG (SHH)–GLI signaling pathway is implicated in prostate cancer. We report expression of SHH–GLI pathway components in adult human prostate cancer, often with enhanced levels in tumors versus normal prostatic epithelia. Blocking the pathway with cyclopamine or anti-SHH antibodies inhibits the proliferation of GLI1+/PSA+ primary prostate tumor cultures. Inversely, SHH can potentiate tumor cell proliferation, suggesting that autocrine signaling may often sustain tumor growth. In addition, pathway blockade in three metastatic prostate cancer cell lines with cyclopamine or through GLI1 RNA interference leads to inhibition of cell proliferation, suggesting cell-autonomous pathway activation at different levels and showing an essential role for GLI1 in human cells. Our data demonstrate the dependence of prostate cancer on SHH–GLI function and suggest a novel therapeutic approach.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=514658Documentos Relacionados
- The therapeutic potential of modulators of the Hedgehog-Gli signaling pathway
- A gradient of Gli activity mediates graded Sonic Hedgehog signaling in the neural tube
- Sonic hedgehog restricts adhesion and migration of neural crest cells independently of the Patched- Smoothened-Gli signaling pathway
- Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development
- MIM/BEG4, a Sonic hedgehog-responsive gene that potentiates Gli-dependent transcription